Clinical Trial

Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)

Study acronym: EPODIG-G
Recruiting
View on ClinicalTrials.gov →
Summary
This is a monocentric, comparative, open-label, randomized parallel group study enrolling elderly subjects hospitalized in Strasbourg Europe Cancerology Institute (ICANS), starting chemotherapy or targeted therapy for the treatment of digestive cancer.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-10-01; most recent amendment 2025-12-30.
Trial Details
NCT Number NCT05066139
Lead Sponsor Centre Paul Strauss
Conditions Digestive System Disease, Neoplasms
Enrollment 144 participants
Start Date 2021-09-17
Primary Completion 2030-10-17 (estimated)
Study Completion 2030-10-17 (estimated)
Updated on ClinicalTrials.gov 2026-01-05